News
We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the ...
Investors in Biogen Inc (Symbol: BIIB) saw new options become available this week, for the July 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...
Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...
Hosted on MSN9mon
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now - MSNWe recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other oversold large ...
Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock, citing concerns over the company's growth prospects and high-risk ...
Check out our BIIB stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
BIIB's revenue has been declining in recent years due to patent expiries and increased competition. For 2023 they have guided to another declining year, in mid-single digit percentage range.
BIIB Price Action: BIIB stock is down 1.46% at $123.17 at publication on Monday. Read Next: Elon Musk’s Tesla Announces 3 Million Model 3 Units Sold Worldwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results